World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 18 April 2017
Main ID:  ChiCTR-OON-15006950
Date of registration: 2015-08-21
Prospective Registration: No
Primary sponsor: Fujian Provincial Hospital, China
Public title: Analysis of the correlation between ABCBl gene rs1045642 single nucleotide polymorphism and clopidogrel resistance in patients with CYP2C19 poor metabolizers
Scientific title: Analysis of the correlation between ABCBl gene rs1045642 single nucleotide polymorphism and clopidogrel resistance in patients with CYP2C19 poor metabolizers
Date of first enrolment: 2015-06-15
Target sample size: non-clopidogrel resistance:50;Clopidogrel resistance:50;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=11687
Study type:  Observational study
Study design:  Non randomized control  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Yanpeng Yang   
Address:  134 Dongjie Road, Fuzhou, China 350001
Telephone: +86 15659113492
Email: 834431557@qq.com
Affiliation:  The Department of Cardiology, Fujian Provincial Hospital
Name: Yansong Guo   
Address:  134 Dongjie Road, Fuzhou, China 350001
Telephone: +86 13509384950
Email: ysguo1234@163.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Upon approval of the ethics committee at our hospital, the patients or their family members have signed informed consent;
2. meet the diagnostic criteria of acute coronary syndrome;
3. Age>=18 years of age;
4. Patients on clopidogrel>7 days.

Exclusion criteria: Patients were excluded if they had a history of bleeding diathesis, chronic oral anticoagulation treatment, contraindications to antiplatelet therapy, hemodynamic instability, platelet count <100*10^9/L OR >300*10^9/L,AST OR ALT>Reference 2 times, Cr>140umol/L.

Age minimum: 18
Age maximum: 90
Gender: Both
Health Condition(s) or Problem(s) studied
acute coronary syndrome
Intervention(s)
non-clopidogrel resistance:NO;Clopidogrel resistance:NO;
Primary Outcome(s)
P2Y12 Reaction Units;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Fujian province health department the backbone project of middle-aged and young talent
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history